Neovasc Inc. Income after Tax

Income after Tax of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Income after Tax growth rates and interactive chart.


Highlights and Quick Summary

  • Income after Tax for the quarter ending March 31, 2022 was $-10.2 Million (a 65.11% increase compared to previous quarter)
  • Year-over-year quarterly Income after Tax increased by 12.47%
  • Annual Income after Tax for 2021 was $-24.9 Million (a -13.26% decrease from previous year)
  • Annual Income after Tax for 2020 was $-28.7 Million (a -18.32% decrease from previous year)
  • Annual Income after Tax for 2019 was $-35.1 Million (a -67.47% decrease from previous year)
  • Twelve month Income after Tax ending March 31, 2022 was $-32.9 Million (a 32.11% increase compared to previous quarter)
  • Twelve month trailing Income after Tax increased by 27.16% year-over-year
Trailing Income after Tax for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
$-32.9 Million $-24.9 Million $-23.2 Million $-25.9 Million
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Income after Tax of Neovasc Inc.

Most recent Income after Taxof NVCN including historical data for past 10 years.

Interactive Chart of Income after Tax of Neovasc Inc.

Neovasc Inc. Income after Tax for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-10.16
2021 $-6.15 $-7.54 $-9.03 $-2.17 $-24.89
2020 $-4.42 $-10.23 $-9.93 $-4.11 $-28.7
2019 $-12.35 $-6.2 $-7.96 $-8.62 $-35.13
2018 $11.68 $-14.64 $-49.15 $-55.88 $-107.98
2017 $-5.03 $-4.7 $-5.34 $-7.85 $-22.91
2016 $37.21 $-29.14 $-83.69 $-10.88 $-86.49
2015 $-7.37 $-7.64 $-6.75 $-4.96 $-26.73
2014 $-6.69 $-4.21 $-5.93 $-0.34 $-17.18
2013 $-2.12 $-1.38 $-1.21 $-1.84 $-6.55
2012 $3.62 $-1.21 $-1.5 $-1.26 $-0.35
2011 $1.8 $-3.86

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.